EarningsQ2 2026 Earnings Report
MX:ASAIN Q2 2026 EPS Results
Actual EPS$6.28
Consensus EPS$4.59
Beat/MissBeat by +$1.69
One Year Ago EPS$2.74
MX:ASAIN Q2 2026 Revenue Results
Actual Revenue$68.91B
Expected Revenue$68.66B
Beat/MissBeat by +$256.90M
YoY Revenue Growth+13.18%
Earnings Announcement Details
QuarterQ2 2026
Date08/06/2026
TimeAfter Close
Conference CallThursday, August 6, 2026
MX:ASAIN Upcoming Earnings
Sendas Distribuidora's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:ASAIN Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a constructive operational and financial picture: management delivered strong cash generation, meaningful deleveraging, a sizable cash buffer (BRL 7.0bn), and robust net income growth (recurring +92.7%), while advancing multiple growth initiatives (private label, pharma, digital partnerships, EV/fuel integration) and ESG progress. Offsetting these positives are persistent macro headwinds — pressured consumption, trade-down behavior among lower-income customers, modest EBITDA margin (~5.6%), dependency on tax-credit timing for reported results, and some execution/regulatory risks for financial and digital projects. On balance the company emphasized resilience, liquidity and strategic initiatives to capture additional share of wallet, suggesting a fundamentally positive tone despite near-term market weakness.Company Guidance
Strong cash position and deleveraging
Gross cash availability of BRL 7.0 billion (cash + receivables), up 20.9% YoY; financial leverage reduced by 0.8x to ~2.7x EBITDA and management guidance that leverage should continue to decline. Cash covers approximately two years of debt maturities.
Recurring and reported net income improvement
Recurring net income reached BRL 344 million, a 92.7% YoY increase; reported (accounting) net income BRL 537 million including nonrecurring tax-credit effects.
Strong operating cash generation and free cash flow
Operational cash generation of ~BRL 3.3 billion; free cash flow generation of ~BRL 2.7 billion; final cash generation after interest/dividends ~BRL 1.4 billion (CapEx post sale-leaseback ~BRL 600 million).
Market share, customer flow and traffic asset
Company reported market share gain within cash & carry (~0.3 ppt) and growth in customer base (total base +2.4%; same-store increase cited ~3.4%). Assaí highlighted 40 million monthly store visitors as a core strategic asset.
Margin resilience and maintained EBITDA
Despite pressured consumption, management reported maintenance of profitability with an EBITDA margin around 5.6%, driven by operational efficiency and store productivity gains.
Commercial & digital expansion initiatives
Private label rollout (~30 SKUs launched so far; some categories already >10% share), Welby supplements in 93 stores with target to reach 300 by end of 2026, 104 stores integrated with iFood (16 million users), iPay pilot in ~30% of stores with 55% adoption by new customers.
New growth avenues (Assaí Pharma, energy, services)
Launched first fully integrated in-store pharmacy (Assaí Pharma); 2 units operational, pipeline potential ~250 units mid-to-long term; CapEx per pharmacy < BRL 400k and estimated investment BRL 100 million for 250 units. Exploring EV charging and fuel station integrations to leverage store traffic.
ESG and people progress
Sustainability advances: ~47% waste reuse, expanded composting and water efficiency initiatives, fourth consecutive year in the B3 ESG index; increased diversity in leadership and >5% trainees recognized by youth employability award.
Reduction in financial expenses
Financial expense impact reduced by ~25% YoY, supported by lower debt levels and a declining average cost of debt.
Operational productivity initiatives
Self-checkout usage grew ~40% YoY and management cited productivity gains with expenses per customer rising below inflation (expenses per customer 1.6% below food/general inflation).
MX:ASAIN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed